findmyKOL
Clinical trialNCT02582684CompletedPhase 2Interventional

Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients

SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsEnrollment122HIV-1 Infection
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Puerto Rico-Aids Crs (5401)

    San Juan, Puerto Rico

United States
  • Ucla Care Center Crs (601)

    Los Angeles, California, United States

  • University of Southern California Crs (1201)

    Los Angeles, California, United States

  • Ucsd, Avrc Crs (701)

    San Diego, California, United States

  • Harbor-Ucla Med. Ctr. Crs (603)

    Torrance, California, United States

  • University of Colorado Hospital Crs (6101)

    Aurora, Colorado, United States

  • Univ. of Miami Aids Crs (901)

    Miami, Florida, United States

  • the Ponce de Leon Center Crs (5802)

    Atlanta, Georgia, United States

  • Northwestern University Crs (2701)

    Chicago, Illinois, United States

  • Rush Univ. Med. Ctr. Actg Crs (2702)

    Chicago, Illinois, United States

  • Brigham and Women'S Hosp. Actg Crs (107)

    Boston, Massachusetts, United States

  • Massachusetts General Hospital Actg Crs (101)

    Boston, Massachusetts, United States

  • Washington University Crs (2101)

    St Louis, Missouri, United States

  • Columbia Physicians and Surgeons Crs (30329)

    New York, New York, United States

  • Cornell Crs (7804)

    New York, New York, United States

  • Weill Med. College of Cornell Univ., the Cornell Ctu -Chelsea (7803)

    New York, New York, United States

  • University of Rochester Adult Hiv Therapeutic Strategies Network Crs (31787)

    Rochester, New York, United States

  • 3201 Chapel Hill Crs

    Chapel Hill, North Carolina, United States

  • Greensboro Crs (3203)

    Greensboro, North Carolina, United States

  • Univ. of Cincinnati Crs (2401)

    Cincinnati, Ohio, United States

  • the Ohio State Univ. Aids Crs (2301)

    Columbus, Ohio, United States

  • Hosp. of the Univ. of Pennsylvania Crs (6201)

    Philadelphia, Pennsylvania, United States

  • the Miriam Hospital Actg Crs (2951)

    Providence, Rhode Island, United States

  • Vanderbilt Therapeutics Crs (3652)

    Nashville, Tennessee, United States

  • 31443 Trinity Health and Wellness Center Crs

    Dallas, Texas, United States

  • Houston Aids Research Team Crs (31473)

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 Dec 2015
Primary completion
28 Feb 2017
Completion
26 Sept 2017
Last update posted
9 May 2018
Registered enrollment
122
Registry id
NCT02582684

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.